Investing Center Preview – Manage your investments and watch your net worth grow.
RHHBY:OTCQX International – Large Cap Stock ()
Roche Holding AG – RHHBY Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
37.65 | -2.37 (-5.92%) | 29.20 - 44.31 | 3.9 million (Above Avg) |
Market data as of 3:59PM 04/04/25. Quotes are delayed by at least 15 min.
Overview - RHHBY
Open | 38.79 |
---|---|
Previous Close | 40.02 |
Day's Range | 37.44 - 39.66 |
Market Cap | 211.6B |
Avg Volume (10 Day) | 2.5M |
Price/Earnings (Trailing 12 Mo.) | 27.4x |
Earnings Per Share (Trailing 12 Mo.) | 0.70238 |
Dividend Yield | 1.35 (3.58%) |
One-Click Scorecard - RHHBY


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Neutral |
---|---|
Avoids excess debt? | Neutral |
Converting sales to profits? | Neutral |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Neutral |
Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Neutral |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Neutral |
Stock is undervalued? | Neutral |
Have investors caught on? | Neutral |
Has support of institutional investors? | Neutral |
Has sufficient liquidity? | Neutral |
Latest Headlines - RHHBY
Genentech and Roche Present Novel Therapeutic and Diagnostic Advancements in Alzheimer’s at AD/PD 2025
Business Wire - Thursday 04/03/2025 9:30 AM ET
Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis
Business Wire - Wednesday 04/02/2025 11:45 AM ET
NRG Oncology and Flatiron Health announce collaboration to leverage leading technology to drive more efficient clinical trials
Business Wire - Wednesday 03/19/2025 9:00 AM ET
Industry Position - RHHBY
RHHBY | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 3.23% | |
Net Income Growth (1yr) | -28.01% | |
Total Debt/Equity | 1.14 | |
LT Debt/Equity | 1.01 | |
Earnings Yield | 3.64% | |
Price/Sales | 3.64 |
Competitors - RHHBY
Company | Last | Change |
---|
Data is delayed by at least 15 min.